Afya (AFYA)

Afya (AFYA) Stock Price & Analysis


AFYA Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$9.66 - $21.91
Previous Close$21.36
Average Volume (3M)190.44K
Market Cap
Enterprise Value$4.51B
Total Cash (Recent Filing)$53.91M
Total Debt (Recent Filing)$2.51B
Price to Earnings (P/E)27.6
Mar 29, 2024
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.77
Shares Outstanding93,722,830
10 Day Avg. Volume200,505
30 Day Avg. Volume190,441
Standard Deviation0.13
Financial Highlights & Ratios
Price to Book (P/B)-2.42
Price to Sales (P/S)0.86
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.71
Enterprise Value/Gross Profit3.07
Enterprise Value/Ebitda6.83
Price Target Upside5.34% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3



Ownership Overview

12.22% Mutual Funds
17.21% Other Institutional Investors
70.57% Public Companies and
Individual Investors


What was Afya’s price range in the past 12 months?
Afya lowest stock price was $9.66 and its highest was $21.91 in the past 12 months.
    What is Afya’s market cap?
    Currently, no data Available
    When is Afya’s upcoming earnings report date?
    Afya’s upcoming earnings report date is Mar 29, 2024 which is in 109 days.
      How were Afya’s earnings last quarter?
      Afya released its earnings results on Nov 13, 2023. The company reported $0.28 earnings per share for the quarter, beating the consensus estimate of $0.276 by $0.004.
        Is Afya overvalued?
        According to Wall Street analysts Afya’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Afya pay dividends?
          Afya does not currently pay dividends.
          What is Afya’s EPS estimate?
          Afya’s EPS estimate is $0.34.
            How many shares outstanding does Afya have?
            Afya has 47,920,067 shares outstanding.
              What happened to Afya’s price movement after its last earnings report?
              Afya reported an EPS of $0.28 in its last earnings report, beating expectations of $0.276. Following the earnings report the stock price went up 2.386%.
                Which hedge fund is a major shareholder of Afya?
                Among the largest hedge funds holding Afya’s share is Dodge & Cox. It holds Afya’s shares valued at 431K.

                  Company Description


                  Afya Ltd. is a medical education group in Brazil. It delivers an end-to-end physician-centric ecosystem that serves and empowers students to be lifelong medical learners through their medical residency preparation, post-graduate programs and continuing medical education activities. The company operates through the following two segments: Education Services and Residency Preparatory & Specialization Programs. The Education Services segment provides educational services through undergraduate and graduate courses related to medicine, other health sciences and other undergraduate programs. The Residency Preparatory & Specialization Programs segment provides residency preparatory courses and medical post-graduate specialization programs, delivering printed and digital content, an online medical education platform and practical medical training. Afya was founded on March 22, 2019 and is headquartered in Sao Paulo, Brazil.

                  Top 5 ETFs holding AFYA

                  Currently, no data available
                  Please return soon. This page is being updated.
                  Up to five ETFs with an Outperform Smart Score that hold AFYA. The ETFs are listed according to market value of AFYA within the ETF

                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Acadia Healthcare
                  Community Health
                  Popular Stocks
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis